Nxstage Medical Inc (NXTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,010 | -31,712 | -25,419 | -17,255 | -8,999 |
| Depreciation Amortization | 5,690 | 22,379 | 16,879 | 11,077 | 5,464 |
| Accounts receivable | -667 | 235 | -303 | -527 | -766 |
| Accounts payable and accrued liabilities | 3,985 | -2,781 | -3,376 | -399 | 940 |
| Other Working Capital | -6,962 | -5,226 | -6,443 | -2,852 | -1,450 |
| Other Operating Activity | 970 | 20,216 | 16,414 | 8,929 | 3,195 |
| Operating Cash Flow | $-2,994 | $3,111 | $-2,248 | $-1,027 | $-1,616 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -623 | -1,556 | -981 | -457 | -225 |
| Other Investing Activity | 0 | 340 | 0 | 0 | 0 |
| Investing Cash Flow | $-623 | $-1,216 | $-981 | $-457 | $-225 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -15 | -54 | -42 | -28 | -15 |
| Common Stock Issued | 1,451 | 85,800 | 5,552 | 2,140 | 883 |
| Common Stock Repurchased | -2,526 | -4,583 | -1,741 | -1,741 | -1,741 |
| Financing Cash Flow | $-1,090 | $81,163 | $3,769 | $371 | $-873 |
| Exchange Rate Effect | 298 | -439 | -286 | -562 | 80 |
| Beginning Cash Position | 104,339 | 21,720 | 21,720 | 21,720 | 21,720 |
| End Cash Position | 99,930 | 104,339 | 21,974 | 20,045 | 19,086 |
| Net Cash Flow | $-4,409 | $82,619 | $254 | $-1,675 | $-2,634 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,994 | 3,111 | -2,248 | -1,027 | -1,616 |
| Capital Expenditure | -623 | -1,556 | -981 | -457 | -225 |
| Free Cash Flow | -3,617 | 1,555 | -3,229 | -1,484 | -1,841 |